[1] Montes LF,Abulafia J,Wilborn WH,et al.Value of histopathology in vitiligo.Int J Dermatol,2003,42:57-61. [2] 全国中西医结合皮肤性病学色素病学组.白癜风临床分型及疗效标准(2003年修定稿).中华皮肤科杂志,2004,37:440. [3] Kitamura R,Tsukamoto K,Harada K,et al.Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis:role of SCF/KIT protein interactions and the downstream effector,MITF-M.J Pathol,2004,202:463-475. [4] Moretti S,Spallanzani A,Amato L,et al.New insights into the pathogenesis of vitiligo:imbalance of epidermal cytokines at sites of lesions.Pigment Cell Res,2002,15:87-92. [5] 李永伟,许爱娥,Ruth Halaban.单味中药提取物对体外培养的黑素细胞酪氨酸酶基因和c-kit基因表达的激活作用.中华皮肤科杂志,2004,37:598-600. [6] Norris A,Todd C,Graham A,et al.The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.Br J Dermatol,1996,134:299-306. [7] Lee AY,Kim NH,Choi WI,et al.Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.J Invest Dermatol,2005,124:976-983. |